Tomoaki Nakata
Second Department of Internal Medicine
Sapporo Medical University School of Medicine
Japan
Name/email consistency: high
- Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. Nakata, T., Wakabayashi, T., Kyuma, M., Takahashi, T., Tsuchihashi, K., Shimamoto, K. Eur. J. Nucl. Med. Mol. Imaging (2005)
- Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Nakata, T., Hashimoto, A., Hase, M., Tsuchihashi, K., Shimamoto, K. Cardiology (2003)
- Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nakata, T., Kobayashi, T., Tamaki, N., Kobayashi, H., Wakabayashi, T., Shimoshige, S., Oh-Hori, K., Hamabe, K., Hirasawa, K., Matsuki, T., Shogase, T., Furudate, M., Shimamoto, K. Nucl. Med. Commun (2000)
- Two- and three-dimensional assessments of myocardial perfusion and function by using technetium-99m sestamibi gated SPECT with a combination of count- and image-based techniques. Nakata, T., Katagiri, Y., Odawara, Y., Eguchi, M., Kuroda, M., Tsuchihashi, K., Hareyama, M., Shimamoto, K. J. Nucl. Cardiol (2000)
- Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy. Nakata, T., Nakahara, N., Sohmiya, K., Okamoto, F., Tanaka, T., Kawamura, K., Shimamoto, K. Jpn. Circ. J. (1999)
- Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. Nakata, T., Miyamoto, K., Doi, A., Sasao, H., Wakabayashi, T., Kobayashi, H., Tsuchihashi, K., Shimamoto, K. J. Nucl. Cardiol (1998)